San Diego drug delivery company Sonrgy snagged exclusive rights to an ultrasound-based nanotech delivery platform conceived at the University of California, San Diego. The license gives Sonrgy global development and marketing rights to the technology, which uses a focused beam of ultrasound to release drugs at the site of a tumor, which are themselves delivered by nanocarriers. According to a statement from Sonrgy Chief Technology Officer Michael Benchimol, "the SonRx technology addresses long-standing challenges related to stability and controlled release in nanoscale drug delivery." Release